A multicenter, randomized trial of flat dosing versus intrapatient dose escalation of single-agent carboplatin as first-line chemotherapy for advanced ovarian cancer: an SGCTG (SCOTROC 4) and ANZGOG study on behalf of GCIG

Author: Banerjee S.   Rustin G.   Paul J.   Williams C.   Pledge S.   Gabra H.   Skailes G.   Lamont A.   Hindley A.   Goss G.   Gilby E.   Hogg M.   Harper P.   Kipps E.   Lewsley L-A   Hall M.   Vasey P.   Kaye S. B.  

Publisher: Oxford University Press

ISSN: 0923-7534

Source: Annals of Oncology, Vol.24, Iss.3, 2013-03, pp. : 679-687

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content